CVS Health Corp (NYSE: CVS) is 6.95% higher on its value in year-to-date trading and has touched a low of $43.56 and a high of $81.03 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CVS stock was last observed hovering at around $46.01 in the last trading session, with the day’s gains setting it 2.0%.
Currently trading at $48.01, the stock is 4.71% and -8.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.78 million and changing 4.35% at the moment leaves the stock -18.48% off its SMA200. CVS registered -40.26% loss for a year compared to 6-month loss of -17.52%. The firm has a 50-day simple moving average (SMA 50) of $52.4174 and a 200-day simple moving average (SMA200) of $58.8962.
The stock witnessed a -14.37% gain in the last 1 month and extending the period to 3 months gives it a -27.22%, and is 8.57% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.48% over the week and 3.53% over the month.
CVS Health Corp (CVS) has around 300000 employees, a market worth around $60.42B and $369.15B in sales. Current P/E ratio is 12.20 and Fwd P/E is 8.09. Profit margin for the company is 1.36%. Distance from 52-week low is 10.22% and -40.75% from its 52-week high. The company has generated returns on investments over the last 12 months (3.34%).
with sales reaching $97.03B over the same period.The EPS is expected to shrink by -40.73% this year, but quarterly earnings will post 3.88% year-over-year. Quarterly sales are estimated to grow 3.43% in year-over-year returns.
CVS Health Corp (CVS) Top Institutional Holders
2362.0 institutions hold shares in CVS Health Corp (CVS), with institutional investors hold 82.80% of the company’s shares. The shares outstanding are 1.26B, and float is at 1.26B with Short Float at 1.44%. Institutions hold 82.68% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 116.35 million shares valued at $6.87 billion. The investor’s holdings represent 9.2341% of the CVS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 100.15 million shares valued at $5.91 billion to account for 7.9485 of the shares outstanding. The other top investors are DODGE & COX which holds 61.68 million shares representing 4.8955% and valued at over $3.64 billion, while CAPITAL WORLD INVESTORS holds 4.4463 of the shares totaling 56.02 million with a market value of $3.31 billion.
CVS Health Corp (CVS) Insider Activity
The most recent transaction is an insider purchase by LUDWIG EDWARD J, the company’s Director. SEC filings show that LUDWIG EDWARD J bought 1,000 shares of the company’s common stock on May 02 ’24 at a price of $53.88 per share for a total of $53879.0. Following the purchase, the insider now owns 21630.0 shares.
CVS Health Corp disclosed in a document filed with the SEC on May 02 ’24 that Mahoney Michael F (Director) bought a total of 9,181 shares of the company’s common stock. The trade occurred on May 02 ’24 and was made at $54.49 per share for $0.5 million. Following the transaction, the insider now directly holds 9356.0 shares of the CVS stock.
Still, SEC filings show that on Feb 16 ’24, Shah Prem S (EVP and Pres-Pharm, Consumer W) disposed off 29,473 shares at an average price of $76.95 for $2.27 million. The insider now directly holds 39,765 shares of CVS Health Corp (CVS).
